Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock

NCT02884011 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2025-01-03

Study results available
· View outcomes & findings →

Summary

Retrospective study to examine the effects of chronic antihypertensive medications on vasopressor dosing in septic shock

Conditions

  • Septic Shock

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Joshua DeMott, Pharm.D. · Rush University Medical Center

  • Ishaq Lat, Pharm.D. · Rush University Medical Center

  • Gourang Patel, Pharm.D. · Rush University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-02-28
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02884011 on ClinicalTrials.gov